基于人工智能从增强MRI虚拟合成甲硫氨酸PET:开发与外部验证研究
本研究开发并验证了一种基于人工智能的图像到图像转换模型,从增强MRI生成合成甲硫氨酸PET图像;在内部测试集中,合成与真实PET的TBRmax、TBRmean和病灶体积的Pearson相关系数分别为0.68、0.76和0.92;在外部测试集中,TBRmax的AUC为0.81,高与低TBRmax组的总生存率差异有统计学意义(2年生存率27% vs 71%,P < .001)。
要点
- 合成甲硫氨酸PET的TBRmax、TBRmean和病灶体积与真实PET的相关系数分别为0.68、0.76和0.92。
- 外部测试集中,TBRmax区分高级别与低级别胶质瘤的AUC为0.81(95% CI: 0.75, 0.86)。
- 外部测试集中,高TBRmax组2年生存率27% vs 低TBRmax组71%,差异有统计学意义(P < .001)。
核心结论
- 基于人工智能模型生成的合成甲硫氨酸PET图像与真实PET图像强相关,在胶质瘤分级和预后评估方面表现出良好性能。
研究设计与样本
- 研究在2007年1月至2018年12月于一所大学医院接受甲硫氨酸PET和增强MRI的患者中开发并验证基于人工智能的合成模型(机构数据集);内部测试集34例;另用两个开源胶质瘤数据库的术前增强MRI作为外部测试集,共344例。
诊断标准与关键数值
- 内部测试集中,合成与真实PET的Pearson相关系数:TBRmax为0.68(95% CI: 0.47, 0.81),TBRmean为0.76(95% CI: 0.59, 0.86),病灶体积为0.92(95% CI: 0.85, 0.95)。
- 外部测试集中,TBRmax区分高级别与低级别胶质瘤的AUC为0.81(95% CI: 0.75, 0.86)。
- 外部测试集中,高TBRmax组2年生存率27% vs 低TBRmax组71%,差异有统计学意义(P < .001)。
临床应用与阅片要点
- 作者认为,基于人工智能模型生成的合成甲硫氨酸PET图像与真实PET强相关,在胶质瘤分级和预后评估方面表现出良好性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Carbon 11 (11C)-methionine is a useful PET radiotracer for the management of patients with glioma, but radiation exposure and lack of molecular imaging facilities limit its use. Purpose To generate synthetic methionine PET images from contrast-enhanced (CE) MRI through an artificial intelligence (AI)-based image-to-image translation model and to compare its performance for grading and prognosis of gliomas with that of real PET. Materials and Methods An AI-based model to generate synthetic methionine PET images from CE MRI was developed and validated from patients who underwent both methionine PET and CE MRI at a university hospital from January 2007 to December 2018 (institutional data set). Pearson correlation coefficients for the maximum and mean tumor to background ratio (TBRmax and TBRmean, respectively) of methionine uptake and the lesion volume between synthetic and real PET were calculated. Two additional open-source glioma databases of preoperative CE MRI without methionine PET were used as the external test set. Using the TBRs, the area under the receiver operating characteristic curve (AUC) for classifying high-grade and low-grade gliomas and overall survival were evaluated. Results The institutional data set included 362 patients (mean age, 49 years ± 19 [SD]; 195 female, 167 male; training, n = 294; validation, n = 34; test, n = 34). In the internal test set, Pearson correlation coefficients were 0.68 (95% CI: 0.47, 0.81), 0.76 (95% CI: 0.59, 0.86), and 0.92 (95% CI: 0.85, 0.95) for TBRmax, TBRmean, and lesion volume, respectively. The external test set included 344 patients with gliomas (mean age, 53 years ± 15; 192 male, 152 female; high grade, n = 269). The AUC for TBRmax was 0.81 (95% CI: 0.75, 0.86) and the overall survival analysis showed a significant difference between the high (2-year survival rate, 27%) and low (2-year survival rate, 71%; P < .001) TBRmax groups. Conclusion The AI-based model-generated synthetic methionine PET images strongly correlated with real PET images and showed good performance for glioma grading and prognostication. Published under a CC BY 4.0 license. Supplemental material is available for this article.
引用
- Takita H, Matsumoto T, Tatekawa H, et al. AI-based Virtual Synthesis of Methionine PET from Contrast-enhanced MRI: Development and External Validation Study. Radiology. 2023. PMID: 37526545. doi:10.1148/radiol.223016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。